Recombinant Human SOX2-TAT #abs01279

Recombinant Human SOX2-TAT #abs01279

Please note that the price mentioned earlier is for reference only. In order to obtain detailed pricing information, please get in touch with our seller, Vecent. It is important to emphasize that the content we provide should be based on the original information, however, it should nevertheless...

Description

Catalog-specification

Delivery time

USD price

abs01279-5ug

1-2 Weeks

138

abs01279-25ug

1-2 Weeks

344

abs01279-1mg

1-2 Weeks

3891

Please note that the price mentioned earlier is for reference only. In order to obtain detailed pricing information, please get in touch with our seller, Vecent. It is important to emphasize that the content we provide should be based on the original information, however, it should nevertheless be substantially different from the dialogue generated by the ChapGPT language model.


Overview

Species

Human

Source

Escherichia coli.

Format

The concentrated solution in 2 × PBS, pH 7.4, with 5% Trehalose was filtered through a 0.2 μm filter and then lyophilized. The resulting product was a powder that was preserved in its original state.

Properties

aa_sequence

GGNSTAAAA GGNQKNSPDR MYNMMETELK PPGPQQTSGG VKRPMNAFMV WSRGQRRKMA QENPKMHNSE ISKRLGAEWK LLSETEKRPF IDEAKRLRAL HMKEHPDYKY RPRRKTKTLM KKDKYTLPGG LLAPGGNSMA AGVNQRMDSY AHMNGWSNGS YSMMQDQLGY PQHPGLNAHG AAQMQPMHRY DVSALQYNSM TSSQTYMNGS PTYSMSYSQQ GTPGMALGSM GSVVKSEASS SPPVVTSSSH SGVGVGAGLG AGVPGMASTT SKNVAKKGSA HQMNLFAAHG LYGGAGMSLP RRDHPNLGAA GMMALPRHWQ QDMGWRKFET RHSGVLWQVQ RLSRTLRHGA LQIGEAIPNL RGWQEFRPHS LYVLLVVILLI LAVAFCFIHR TRLVYLEQFL RNAALFTYDV YAGRAVHNTV SHVLAGVFSD VTAYVPRPST PLNQAPWALV RSGRTPHVGG VGKGTMIDMF DYYLMAKMAA QLMLDDIKGR MILEMYNSTL VAAQRFYGCI TPQVHRDETS FQEGGGLPEM KNNSPPINAI MEFNQSMTVT KKTPMNSFTT NSQSSGQQTN RMEYVYSIML SEPNRMGLNL MSSPQPQKQP GGGNSTAAAA GGNQKNSPDR.

Concentration

> 95 % by SDS-PAGE and HPLC analyses.

Endotoxin_level

According to the LAL method, the Recombinant HumanSOX2-TAT contains an amount lower than 1 EU/μg. To provide a closely matching content, the text can be rearranged as follows: The determination using the LAL method confirmed that the Recombinant HumanSOX2-TAT has a content of less than 1 EU/μg.

Reconstitution

Before opening the vial, it is recommended to briefly centrifuge it to ensure that the contents settle at the bottom. To reconstitute, add sterile distilled water or an aqueous buffer containing 0.1% BSA to achieve a concentration of 0.1-1.0 mg/ml. It is advisable to divide the stock solutions into smaller working aliquots and store them at temperatures of -20 °C or below. Any further dilutions should be prepared using appropriate buffered solutions.

Stability & Storage

For optimal storage conditions of this lyophilized preparation, it is recommended to keep it at a temperature range of 2-8 °C. However, for long-term storage, it should be stored at -20 °C, preferably in a desiccated state. Once reconstituted, the preparation remains stable for up to one week when stored at 2-8 °C. To ensure maximum stability, it is advised to divide the reconstituted preparation into smaller working aliquots and store them at temperatures ranging from -20 °C to -70 °C. It is important to avoid subjecting the preparation to repeated freeze/thaw cycles as it may affect its stability.

Target

Accession

P48431

Gene IDs

6657

References

References

1. M Stevanovic, O Zuffardi, J Collignon, et al. 1994. Mamm Genome, 5: 640-2.

2. J Fantes, NK Ragge, SA Lynch, et al. 2003. Nat Genet, 33: 461-3.

3. A Rizzino. 2009. Wiley Interdiscip Rev Syst Biol Med, 1: 228-36.

4. K Takahashi, K Tanabe, M Ohnuki, et al. 2007. Cell, 131: 861-72.


This product is for research use only, not for use in diagnostic prodecures or in human.


Hot Tags: recombinant human sox2-tat #abs01279, China recombinant human sox2-tat #abs01279 suppliers

You Might Also Like

Shopping Bags